Bearing in mind that (i) TF expression is characteristic in endothelial dysfunction and inflammatory damage [28] and (ii) COVID-19 is characterized by endotheliopathy [17,19], we hypothesized that FVIIa-AT plasma levels may be increased in patients with SARS-CoV-2 infection. Here, TF is linked to endothelial dysfunction.